scholarly journals Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form.

1990 ◽  
Vol 1 (8) ◽  
pp. 577-584 ◽  
Author(s):  
K Usuki ◽  
L Norberg ◽  
E Larsson ◽  
K Miyazono ◽  
U Hellman ◽  
...  

Platelet-derived endothelial cell growth factor (PD-ECGF) was purified to homogeneity from human term placenta, an organ characterized by extensive angiogenesis. N-terminal amino acid sequencing revealed that placental PD-ECGF was proteolytically processed at Thr-6, in contrast to PD-ECGF purified from human platelets, which is processed at Ala-11. The purified factor stimulated porcine aortic endothelial cells as well as two choriocarcinoma cell lines. Immunohistochemical staining revealed that PD-ECGF was present in the connective tissue cells of the placenta. The possibility that PD-ECGF is involved in the development of the placenta is discussed.

2009 ◽  
Vol 87 (6) ◽  
pp. 883-893 ◽  
Author(s):  
Thiagarajan Hemalatha ◽  
Mitali Tiwari ◽  
Chidambaram Balachandran ◽  
Bhakthavatsalam Murali Manohar ◽  
Rengarajulu Puvanakrishnan

This study explores the angiogenic and antiapoptotic activities of platelet-derived endothelial cell growth factor (PDECGF) in rat aortic endothelial cells. The effects of PDECGF on rat aortic endothelial cell (RAEC) proliferation, migration, chemotaxis, and tubule formation were investigated in vitro at various concentrations viz., 1, 2, 4, 8, 16, and 32 ng·mL–1 on endothelial cells. Endothelial cells were induced with hypoxic stress and the antiapoptotic effects of PDECGF were analysed by cell survival assay, fluorescence microscopy, cell viability assay, and flow cytometry. The results demonstrated the angiogenic potential of PDECGF on endothelial cells in a dose-dependent manner. PDECGF at 16 and 32 ng·mL–1 increased cell proliferation (>80%), induced cell migration (>4 fold), stimulated chemotaxis (>2 fold), and increased tubule formation (>3 fold) compared with the control. Studies on hypoxic stress revealed the antiapoptotic nature of PDECGF on endothelial cells. PDECGF treatment enhanced cell survival by 14%, as well as cell viability by 13%, and decreased the percentage of apoptotic cells by 13% as demonstrated by fluorescence-activated cell sorter studies (FACS). In conclusion, this study demonstrated the angiogenic and antiapoptotic potentials of PDECGF on RAEC.


1999 ◽  
Vol 19 (10) ◽  
pp. 2340-2347 ◽  
Author(s):  
Mihaela C. Ignatescu ◽  
Elisabeth Gharehbaghi-Schnell ◽  
Ali Hassan ◽  
Shahrzad Rezaie-Majd ◽  
Irina Korschineck ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document